Moreover, an in silico analysis of TCGA pancreatic cancer dataset reported high expression levels of SCN7A in the high immune and stromal score groups, which were associated with better OS of the patients [35], suggesting the prognostic value of SCN7A for patients with pancreatic cancer. Here, SCN7A is linked to familial pancreatic carcinoma.